Company Data
Coherus BioSciences Inc.
Ticker
CHRS
Current Price
$1.165 -1.27%
Market Cap
$135.4M
Price Target
Refer to Report
Volume
311.0K
52wk Range
$0.6603 - $2.43
Overview
Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.